Immunovant (IMVT) Operating Leases (2020 - 2024)
Immunovant's (IMVT) quarterly Operating Leases came in at $138000.0 in Q1 2024, up 193.62% YoY from $47000.0 in Q2 2023, and up 193.62% on a QoQ basis from $47000.0 in Q1 2023.
Immunovant (IMVT) Operating Leases (2020 - 2024) Analysis & Trends
Immunovant (IMVT) has 5 years of Operating Leases data on file, last reported at $138000.0 in Q1 2024.
- Quarterly Operating Leases rose 193.62% year-over-year to $138000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $138000.0 (up 193.62% YoY) and the FY2024 annual result came in at $138000.0, up 193.62% from the prior year.
- Operating Leases improved to $138000.0 in Q1 2024, from $47000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $4.2 million in Q2 2020 to a low of $47000.0 in Q1 2023.
- A 5-year average of $1.6 million and a median of $1.7 million in 2021 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases tumbled 96.14% — and 2024, when it jumped 193.62%.
- Tracing IMVT's Operating Leases over 5 years: stood at $2.4 million in 2020, then slipped by 29.77% to $1.7 million in 2021, then tumbled by 81.79% to $306000.0 in 2022, then sank by 84.64% to $47000.0 in 2023, then jumped by 193.62% to $138000.0 in 2024.
- The last three Operating Leases figures came in at $138000.0 (Q1 2024), $47000.0 (Q1 2023), and $306000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immunovant | 8.63 Bn | 7.83 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 138,000.00 |
| Mar 31, 2023 | 47,000.00 |
| Dec 31, 2022 | 306,000.00 |
| Sep 30, 2022 | 614,000.00 |
| Jun 30, 2022 | 919,000.00 |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.68 Mn |
| Sep 30, 2021 | 1.95 Mn |
| Jun 30, 2021 | 1.97 Mn |
| Mar 31, 2021 | 2.24 Mn |
| Dec 31, 2020 | 2.39 Mn |
| Sep 30, 2020 | 2.68 Mn |
| Jun 30, 2020 | 4.20 Mn |